Author

Rajdeep Brar

Observed name: R. Brar

Institution: Trevena, Inc. (United States)

Observed institutions: Hofstra University, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, Trevena, Inc. (United States)

ORCID: 0000-0003-0721-8179

Observed ORCID: 0000-0003-0721-8179

OpenAlex ID: A5068550103

First-Time Prescribing of GLP-1 Receptor Agonists from 2018-2023: A Descriptive Analysis

2023 · Patricia J Rodriguez, Samuel Gratzl, et al. · medRxiv · 5

HSD30 Real-World Prescribing of GLP-1s Among Patients With Overweight or Obesity in the United States

2023 · P. Rodriguez, B. Cartwright, et al. · Value in Health · 1

The temporal relationship between preeclampsia and heart failure

2023 · Charlotte Baker, Peter D Smits, et al. · medRxiv · 1

Authors' Response to Peer Reviews of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study”

2021 · Mark Jarrett, Warren Licht, et al. · JMIRx Med

Works count: 4

Citation count: 7

H-index: 1

I10-index: